Reactions to small pox vaccine in naïve and previously-vaccinated individuals - PubMed (original) (raw)
. 2005 Jul 14;23(32):4185-7.
doi: 10.1016/j.vaccine.2004.10.052. Epub 2005 Apr 15.
Affiliations
- PMID: 15916840
- DOI: 10.1016/j.vaccine.2004.10.052
Reactions to small pox vaccine in naïve and previously-vaccinated individuals
Cressida Auckland et al. Vaccine. 2005.
Abstract
Two hundred health care workers in England and Wales were vaccinated with the Lister/Elstree strain of the vaccinia virus, and completed health diaries for 21 days or until the lesion had scabbed over. Pain and temperature were measured daily, and all other symptoms recorded freehand by the vaccinee. One hundred and forty two (71%) vaccinees reported pain, of which 25% considered it to be moderate or severe; 32 vaccinees (16%) recorded a temperature of >37.7 degrees C, two of which exceeded 39 degrees C. Other, mainly trivial, adverse events were common; itch was reported in 72%, erythema in 27%, axillary pain or lymphadenopathy in 38%, malaise or flu-like symptoms in 40% and headache in 23%. The incidences of minor adverse events were lower in re-vaccinees, compared with naïve vaccine recipients, significantly so in the case of erythema and general malaise (p=0.001 and 0.006, respectively), perhaps reflecting pre-existing immunity. Major adverse events occurred in two vaccinees (hospital admission, one with cellulitis and one with headache and possible encephalitis), and a further five were treated with antibiotics for local cellulitis. This is the first study to report results derived from active follow-up by diaries in recipients of the Lister/Elstree strain of vaccinia, and to document reductions in trivial adverse events in re-vaccinees.
Similar articles
- Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Wharton M, et al. MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16. MMWR Recomm Rep. 2003. PMID: 12710832 - Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J, Casey CG, Bell DM; Centers for Disease Control and Prevention. Cono J, et al. MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28. MMWR Recomm Rep. 2003. PMID: 12617510 - Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients.
Muralles AA, Ray P, Black S, Shinefield H, Casey CG, Campbell S, Chen RT. Muralles AA, et al. Vaccine. 2006 Jan 23;24(4):476-84. doi: 10.1016/j.vaccine.2005.07.089. Epub 2005 Aug 30. Vaccine. 2006. PMID: 16216396 - Smallpox vaccine: contraindications, administration, and adverse reactions.
Maurer DM, Harrington B, Lane JM. Maurer DM, et al. Am Fam Physician. 2003 Sep 1;68(5):889-96. Am Fam Physician. 2003. PMID: 13678138 Review. - Smallpox vaccination: a review, part II. Adverse events.
Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Fulginiti VA, et al. Clin Infect Dis. 2003 Jul 15;37(2):251-71. doi: 10.1086/375825. Epub 2003 Jul 10. Clin Infect Dis. 2003. PMID: 12856218 Review.
Cited by
- Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.
Sato H. Sato H. Environ Health Prev Med. 2011 Sep;16(5):281-9. doi: 10.1007/s12199-010-0200-z. Epub 2010 Dec 21. Environ Health Prev Med. 2011. PMID: 21431786 Free PMC article. Review. - The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
Volkmann A, Williamson AL, Weidenthaler H, Meyer TPH, Robertson JS, Excler JL, Condit RC, Evans E, Smith ER, Kim D, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG. Volkmann A, et al. Vaccine. 2021 May 21;39(22):3067-3080. doi: 10.1016/j.vaccine.2020.08.050. Epub 2020 Oct 17. Vaccine. 2021. PMID: 33077299 Free PMC article. Review. - Smallpox vaccines for biodefense: need and feasibility.
Artenstein AW, Grabenstein JD. Artenstein AW, et al. Expert Rev Vaccines. 2008 Oct;7(8):1225-37. doi: 10.1586/14760584.7.8.1225. Expert Rev Vaccines. 2008. PMID: 18844596 Free PMC article. Review. - The Effect of Vaccination with Live Attenuated Neethling Lumpy Skin Disease Vaccine on Milk Production and Mortality-An Analysis of 77 Dairy Farms in Israel.
Morgenstern M, Klement E. Morgenstern M, et al. Vaccines (Basel). 2020 Jun 19;8(2):324. doi: 10.3390/vaccines8020324. Vaccines (Basel). 2020. PMID: 32575395 Free PMC article. - Immunomodulator-based enhancement of anti smallpox immune responses.
Martínez O, Miranda E, Ramírez M, Santos S, Rivera C, Vázquez L, Sánchez T, Tremblay RL, Ríos-Olivares E, Otero M. Martínez O, et al. PLoS One. 2015 Apr 13;10(4):e0123113. doi: 10.1371/journal.pone.0123113. eCollection 2015. PLoS One. 2015. PMID: 25875833 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials